Pancreatic cancer surgery trial ends early – only 5 patients enrolled
NCT ID NCT06122480
First seen Feb 19, 2026 · Last updated May 12, 2026 · Updated 8 times
Summary
This study looked at whether surgically removing small tumors in the liver or lungs (called oligometastases) could help people with pancreatic cancer live longer. All participants had already received chemotherapy before surgery. The trial was stopped early after enrolling only 5 people, so we don't have enough information to know if the approach works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.